This Pre-Solicitation opportunity from Department Of Veterans Affairs was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6505--Esomeprazole Capsules (VA-27-00001026)

Closed

36E79726R0027Federal

Submission Closed06/02/2026, 07:30:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

METOPROLOL TARTRATEThe contract pertains to the procurement of Metoprolol Tartrate, identified by the National Stock Number 6505-01-615-1537, with a requested quantity of one unit under purchase request number 7017142424. The solicitation, numbered SPE2DP-26-T-3815, was posted by the Defense Logistics Agency, a branch of the Department of Defense, on June 16, 2026. The deadline for responses to this solicitation is June 22, 2026, indicating a brief window for bid submissions. This contract is categorized as a solicitation from a federal agency, with no specified type of set-aside or NAICS code provided. The place of performance and office location details are unspecified beyond being within the United States. The solicitation is accessible through the Defense Logistics Agency’s bidding system, and it appears focused on securing this specific pharmaceutical item for defense-related use.

Defense Logistics Agency

POSTED

DEADLINE

6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

Custom Sterile Compounding of Total Parenteral Nutrition (TPN) FormulationsThe contract involves the manufacture and delivery of patient-specific, sterile Total Parenteral Nutrition (TPN) formulations, including branded products such as TrophAmin®, Plenamine, Nutrilipid®, and SMOF Lipid®. These formulations must be provided in volumes ranging from 1000 to over 3000 mL, with an absolute requirement for zero tolerance for deviations, ensuring strict adherence to quality and safety standards. This precision is critical given the nature of the products and their use in patient care. Administered by the Defense Health Agency Hcd West under the Department of Defense, the contract is categorized under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract is structured as a subcontract with a deadline for responses set for June 30, 2026. Performance is designated for an area identified by the zip code 98431. The contract underscores the importance of reliable, high-quality sterile compounding to meet defense health requirements with strict compliance to specifications and timelines.

Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 14 days

AI Contract Overview

The Department of Veterans Affairs (VA) National Acquisition Center plans to issue a Request for Proposal (RFP) for the procurement of Esomeprazole Magnesium Capsules intended for use across multiple federal health entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract will be awarded to a single responsible offeror capable of ensuring a continuous supply of the medication. The base contract term will be one year, with four additional pre-priced option years. Distribution of the capsules will occur through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. Offerors must provide the exact drug name as labeled and a unique National Drug Code (NDC) specific to their product, with strict labeling requirements prohibiting overlaying labels and specifying safety cap and packaging dimensions to maintain consistency, safety, and traceability. The solicitation, identified as 36E79726R0027, will be issued electronically in a commercial item format around June 9, 2026, with proposals due by June 23, 2026. The procurement falls under the NAICS code 325412. Estimated annual usage includes various package sizes of Esomeprazole 20 mg and 40 mg enteric-coated capsules, ranging from 30-count to 1000-count bottles, with total demand for the most common sizes reaching well into the hundreds of thousands of bottles. Interested parties must monitor the SAM.gov site for solicitation amendments and submit offers electronically, as no paper copies will be provided. The designated contact for inquiries is James Sullivan, Contract Specialist at the VA.

General Info

VA seeks one supplier for Esomeprazole Capsules, one-year base plus four option years, electronic proposals.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

Set-Aside

NONE

Documents

(1)

RFP 36E79726R0027 for Esomeprazole Capsules

DOCX•presolicitation

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 19

Presolicitation

Response DeadlineJun 2

Deadline has passed

Submission Closed

06/02/2026, 07:30:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Contacts1 person available

OfficeHINES, IL, 60141, USA

Organization / Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Office AddressHINES, IL, 60141, USA

Contacts

James SullivanContract Specialist

contact@example.gov

+1 (555) 000-0000

Full Description

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0027 for an unrestricted procurement for Esomeprazole Magnesium Capsules, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 &4, 30 count bottles; line items 2 & 5, 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0027 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 9, 2026, with a tentative closing date of June 23, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Sullivan. Questions can be e-mailed to james.sullivan3@va.gov.

The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 ESOMEPRAZOLE 20MG CAP,EC 30 55,112 2 ESOMEPRAZOLE 20MG CAP,EC 90 21,059 3a ESOMEPRAZOLE 20MG CAP,EC 500 3,884 OR OR OR OR 3b ESOMEPRAZOLE 20MG CAP,EC 1000 1,942 4 ESOMEPRAZOLE 40MG EC CAP 30 299,341 5 ESOMEPRAZOLE 40MG EC CAP 90 22,995 6a ESOMEPRAZOLE 40MG EC CAP 500 11,208 OR OR OR OR 6b ESOMEPRAZOLE 40MG EC CAP 1000 5,604